Exact Mass: 195.1025998
Exact Mass Matches: 195.1025998
Found 500 metabolites which its exact mass value is equals to given mass value 195.1025998,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tyrosine methylester
Tyrosine methylester, also known as Tyrosine methyl ester hydrochloride, (L)-isomer or Tyr-ome, is classified as a tyrosine or a Tyrosine derivative. Tyrosines are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Tyrosine methylester is considered to be a slightly soluble (in water) and a very weak acidic compound. Tyrosine methylester can be found in humans. KEIO_ID T032 H-Tyr-OMe, an amino acid, is an endogenous metabolite[1].
6-hydroxymethyl-7,8-dihydropterin
2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-ol, also known as hmdp cpd, belongs to pterins and derivatives class of compounds. Those are polycyclic aromatic compounds containing a pterin moiety, which consist of a pteridine ring bearing a ketone and an amine group to form 2-aminopteridin-4(3H)-one. 2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-ol is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-ol can be found in a number of food items such as cardoon, sunburst squash (pattypan squash), climbing bean, and fenugreek, which makes 2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-ol a potential biomarker for the consumption of these food products. 2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-ol exists in E.coli (prokaryote) and yeast (eukaryote).
Metyrosine
Metyrosine is only found in individuals that have used or taken this drug. It is an inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. (Martindale, The Extra Pharmacopoeia, 30th ed)Metyrosine inhibits tyrosine hydroxylase, which catalyzes the first transformation in catecholamine biosynthesis, i.e., the conversion of tyrosine to dihydroxyphenylalanine (DOPA). Because the first step is also the rate-limiting step, blockade of tyrosine hydroxylase activity results in decreased endogenous levels of catecholamines and their synthesis. This consequently, depletes the levels of the catecholamines dopamine, adrenaline and noradrenaline in the body,usually measured as decreased urinary excretion of catecholamines and their metabolites. One main end result of the catecholamine depletion is a decrease in blood presure. C - Cardiovascular system > C02 - Antihypertensives > C02K - Other antihypertensives > C02KB - Tyrosine hydroxylase inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C2155 - Tyrosine Hydroxylase Inhibitor D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
benalfocin
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
2-Phenyl-1,3-propanediol monocarbamate
2-Phenyl-1,3-propanediol monocarbamate is a metabolite of felbamate. Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. (Wikipedia)
L-Homotyrosine
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
alpha-[3-(Nitrosoamino)propyl]-3-pyridinemethanol
C9H13N3O2 (195.10077180000002)
alpha-[3-(Nitrosoamino)propyl]-3-pyridinemethanol is considered to be slightly soluble (in water) and acidic
3-Methyl-l-tyrosine
A tyrosine derivative that is L-tyrosine in which the hydrogen at position 3 on the phenyl ring is replaced by a methyl group.
Methacholine chloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D008916 - Miotics D019141 - Respiratory System Agents > D016085 - Bronchoconstrictor Agents Methacholine (Acetyl-β-methylcholine) choride is a potent muscarinic-3 (M3) agonist. Methacholine choride acts directly on acetylcholine receptors on smooth muscle causing bronchoconstriction and airway narrowing. Methacholine choride shows a high sensitivity to identify bronchial hyperresponsiveness (BHR). Methacholine choride can be used to measure airway hyperresponsiveness (AHR) as a diagnostic aid in the assessment of individuals with asthma-like symptoms and normal resting expiratory flow rates[1][2][3][4].
Surinamine
D010592 - Pharmaceutic Aids > D011310 - Preservatives, Pharmaceutical > D010226 - Parabens
N-Acetyldopamine
N-Acetyldopamine also known as NADA is an acetylated form of dopamine. It is an endogenously produced derivative or metabolite of dopamine. It belongs to the family of compounds known as catecholamines and derivatives. These are compounds containing 4-(2-aminoethyl) pyrocatechol [4-(2-aminoethyl) benzene-1,2-diol] or a derivative thereof. While NADA has been found in the human liver, kidney, and urine, it is unclear what its role is in mammal physiology (PMID: 16179545). NADA exists in both free and conjugated (glucuronide) forms. Conjugated NADA accounts for about 90\\\% of the total excretion of NADA. Urinary excretion of total N-acetyldopamine averages 0.485 micromoles/day in healthy humans (PMID: 6513727). The concentration of NADA is thirteen times higher in children with neuroblastoma than in normal subjects (PMID: 1321164). NADA is known to be a sepiapterin reductase inhibitor (PMID: 16179545). N-acetyldopamine has been shown to inhibit lipopolysaccharide-induced lipid peroxidation in rat brains (PMID: 16179545). N-acetyldopamine (NADA) is a catecholamine that is used by insects as sclerotizing precursors to harden their cuticle[1].
N-methyl-4,6,7-trihydroxy-1,2,3,4-tetrahydroisoquinoline
This compound belongs to the family of Isoquinolines and Derivatives. These are aromatic polycyclic compounds containing an isoquinoline moiety, which consists of a benzene ring fused to a pyridine ring and forming benzo[c]pyridine
2-hydroxymexiletine
C11H17NO2 (195.12592220000002)
2-hydroxymexiletine is a metabolite of mexiletine. Mexiletine (sold under the trade name Mexitil) belongs to the Class IB anti-arrhythmic group of medicines. It is used to treat arrhythmias within the heart, or seriously irregular heartbeats. It slows conduction in the heart and makes the heart tissue less sensitive. Dizziness, heartburn, nausea, nervousness, trembling, unsteadiness are common side effects. It is available in injection and capsule form. (Wikipedia)
p-hydroxymexiletine
C11H17NO2 (195.12592220000002)
p-hydroxymexiletine is a metabolite of mexiletine. Mexiletine (sold under the trade name Mexitil) belongs to the Class IB anti-arrhythmic group of medicines. It is used to treat arrhythmias within the heart, or seriously irregular heartbeats. It slows conduction in the heart and makes the heart tissue less sensitive. Dizziness, heartburn, nausea, nervousness, trembling, unsteadiness are common side effects. It is available in injection and capsule form. (Wikipedia)
Meglumine
Meglumine, also known as megluminum or methylglucamine, belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. Meglumine is soluble (in water) and a very weakly acidic compound (based on its pKa).
4-Hydroxy-3-methoxymethamphetamine
C11H17NO2 (195.12592220000002)
4-Methoxy-3-[2-(methylamino)propyl]phenol
C11H17NO2 (195.12592220000002)
2-Amino-4-hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine
8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine
Racemetirosine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
[3-(2-Aminopropyl)-6-methylidenecyclohexa-1,3-dien-1-yl]methanediol
C11H17NO2 (195.12592220000002)
(2E,4E)-N-isobutyl-6-oxohepta-2,4-dienamide
C11H17NO2 (195.12592220000002)
2,5-Dimethoxy-4-methylphenethylamine
C11H17NO2 (195.12592220000002)
4-Hydroxy-3-methoxymethamphetamine
C11H17NO2 (195.12592220000002)
1R-2-(2,6,6-trimethyl-4-oxo-2-cyclohexenyl)ethanamide|glaucenamide
C11H17NO2 (195.12592220000002)
N-[2-(3,4-dimethoxyphenyl)ethylidene]hydroxylamine
N-A-BOC-N-D-Z-D-LYSINE
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
1-methyl-1,2,3,4-tetrahydroisoquinoline-4,6,7-triol
4-(3-azidopropyl)cyclohexane-1,3-dione
C9H13N3O2 (195.10077180000002)
L-beta-Homotyrosine
Acquisition and generation of the data is financially supported in part by CREST/JST.
2,2-(p-Tolylazanediyl)diethanol
C11H17NO2 (195.12592220000002)
CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4749; ORIGINAL_PRECURSOR_SCAN_NO 4747 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4763; ORIGINAL_PRECURSOR_SCAN_NO 4760 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4766; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4776; ORIGINAL_PRECURSOR_SCAN_NO 4775 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4785; ORIGINAL_PRECURSOR_SCAN_NO 4783 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4781; ORIGINAL_PRECURSOR_SCAN_NO 4778
Benzenemethanol, 2-(2-aminopropoxy)-3-methyl-
C11H17NO2 (195.12592220000002)
a-[1-(ethylamino)ethyl]-p-hydroxy-Benzyl alcohol
C11H17NO2 (195.12592220000002)
6,7-Dimethyltetrahydropterin
N-Acetyldopamine
A secondary carboxamide obtained by formal condensation of the carboxy group of acetic acid with the amino group of dopamine. A dopamine metabolite. N-acetyldopamine (NADA) is a catecholamine that is used by insects as sclerotizing precursors to harden their cuticle[1].
2,3,4,5-TETRAHYDRO-1H-1,5-METHANO-3-BENZAZEPINE HYDROCHLORIDE
2-amino-3-(4-hydroxy-2-methylphenyl)propanoic acid
((3R,4S)-4-(3-fluorophenyl)pyrrolidin-3-yl)methanol
C11H14FNO (195.10593659999998)
6,8-DIMETHYL-4-OXO-4H-CHROMENE-2-CARBOXYLIC ACID
C11H17NO2 (195.12592220000002)
2-Amino-3-(4-hydroxyphenyl)propanehydrazide
C9H13N3O2 (195.10077180000002)
2-(3-(6-METHYL-2-PYRIDYL)PROPOXY)ETHANOL
C11H17NO2 (195.12592220000002)
Methyl 4-amino-4,5,6,7-tetrahydrobenzofuran-3-carboxylate
(5-METHYL-PYRIDIN-2-YLOXY)-ACETIC ACID ETHYL ESTER
Carpronium chloride
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist
Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate
(6-Isopropyl-2-methoxypyridin-3-yl)boronic acid
C9H14BNO3 (195.10666840000002)
2-(3-aminopropylamino)pyridine-3-carboxylic acid
C9H13N3O2 (195.10077180000002)
Ethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
C9H13N3O2 (195.10077180000002)
5,6-DIETHYL-3-HYDROXYPYRAZINE-2-CARBOXAMIDE
C9H13N3O2 (195.10077180000002)
3-(4-aminophenyl)-1-methoxy-1-methylurea
C9H13N3O2 (195.10077180000002)
Glycine,N-(aminoiminomethyl)-N-methyl-ethyl ester, hydrochloride (1:1)
3-AMINO-2-[(2-AMINOETHYL)AMINO]BENZOIC ACID
C9H13N3O2 (195.10077180000002)
2-(4-Methoxyphenoxy)-N,N-dimethylethanamine
C11H17NO2 (195.12592220000002)
ethyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H13N3O2 (195.10077180000002)
tert-butyl (1R,4S)-5-azabicyclo[2.2.1]hept-2-ene-5-carboxylate
C11H17NO2 (195.12592220000002)
3-AMINO-3-(2-HYDROXY-3-METHYL-PHENYL)-PROPIONIC ACID
Urea, N-(4-methoxy-2-methyl-3-pyridinyl)-N-methyl- (9CI)
C9H13N3O2 (195.10077180000002)
Urea, N-(3-hydroxy-2-pyridinyl)-N-propyl- (9CI)
C9H13N3O2 (195.10077180000002)
Urea, 3-(6-methoxy-3-pyridyl)-1,1-dimethyl- (8CI)
C9H13N3O2 (195.10077180000002)
4,5,6,7-Tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid ethyl ester
C9H13N3O2 (195.10077180000002)
5-METHOXY-3,4-DIHYDRO-1,7-NAPHTHYRIDIN-2(1H)-ONE
C11H17NO2 (195.12592220000002)
5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-1,2,3-TRIAZOLE
C8H14BN3O2 (195.11790140000002)
1H-3-Benzazepine, 8-chloro-2,3,4,5-tetrahydro-1-Methyl-, (1S)-
3-[benzyl(methyl)amino]propane-1,2-diol
C11H17NO2 (195.12592220000002)
aminometradine
C9H13N3O2 (195.10077180000002)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
Amisometradine
C9H13N3O2 (195.10077180000002)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
2-amino-6-(2-methylpropyl)pyrimidine-4-carboxylic acid
C9H13N3O2 (195.10077180000002)
Hydrazinecarboxamide,2-[1-(2-fluorophenyl)ethylidene]-
2-{[(4-METHYLPHENYL)SULFONYL]AMINO}BENZOIC ACID
C11H17NO2 (195.12592220000002)
(2-ISOBUTOXYPYRIDIN-3-YL)BORONIC ACID
C9H14BNO3 (195.10666840000002)
5-methyl-3-nitro-N-propan-2-ylpyridin-2-amine
C9H13N3O2 (195.10077180000002)
N-(3-FLUORO-PHENYL)-2,2-DIMETHYL-PROPIONAMIDE
C11H14FNO (195.10593659999998)
ethyl 1-cyanocycloheptane-1-carboxylate
C11H17NO2 (195.12592220000002)
3-(5-Formyl-2,4-dimethyl-1H-pyrrol-3-yl)propanoic acid
ethyl 4-ethyl-3,5-dimethyl-1h-pyrrole-2-carboxylate
C11H17NO2 (195.12592220000002)
N,N-Diethyl-5-nitro-2-pyridinamine
C9H13N3O2 (195.10077180000002)
4-(3-METHOXY-PHENYLAMINO)-BUTAN-1-OL
C11H17NO2 (195.12592220000002)
methyl 1-methyl-4-propionyl-1H-pyrrole-2-carboxylate
formic acid, compound with 2,2,2-nitrilotris[ethanol] (1:1)
8-hydroxy-8-(trifluoromethyl)-3-azabicyclo[3.2.1]octane
C8H12F3NO (195.08709379999996)
{2-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}METHANOL
C11H17NO2 (195.12592220000002)
2-[(1-methyl-2-phenoxyethyl)amino]ethanol
C11H17NO2 (195.12592220000002)
1H-Pyrrole-2-carboxylicacid, 4-formyl-3,5-dimethyl-, ethyl ester
2-(4-fluorophenyl)-2-methylmorpholine
C11H14FNO (195.10593659999998)
(2-METHOXY-BENZYL)-(2-METHOXY-ETHYL)-AMINE
C11H17NO2 (195.12592220000002)
(2-Morpholinopyrimidin-5-yl)methanol
C9H13N3O2 (195.10077180000002)
3-Pyridinecarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-oxo-, ethyl ester
4-(2-FLUORO-PHENYL)-PIPERIDIN-4-OL
C11H14FNO (195.10593659999998)
1-Propanamine,3-(2-phenoxyethoxy)-
C11H17NO2 (195.12592220000002)
ETHYL 2,4-DIMETHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBOXYLATE
(R)-methyl 2-(isopropylamino)butanoate hydrochloride
tert-butyl N-pyridazin-3-ylcarbamate
C9H13N3O2 (195.10077180000002)
4-(trifluoromethyl)cyclohexane-1-carboxamide
C8H12F3NO (195.08709379999996)
2-AMINO-1-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)ETHANOL
(4-CHLORO-6-(METHYLTHIO)PYRIMIDIN-5-YL)METHANAMINE
1-(2-THIENYLMETHYL)PIPERIDIN-4-YL]METHANOL HYDROCHLORIDE
C11H17NO2 (195.12592220000002)
3-(3,4-Dimethoxyphenyl)-1-propanamine
C11H17NO2 (195.12592220000002)
Ethyl 5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate
C9H13N3O2 (195.10077180000002)
3-AMINO-3-(4-HYDROXY-3-METHYL-PHENYL)-PROPIONIC ACID
3-(piperidin-1-ylcarbonyl)-1H-1,2,4-triazol-5-amine(SALTDATA: FREE)
oxazol-2-ylboronic acid pinacol ester
C9H14BNO3 (195.10666840000002)
Lorcaserin
A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
Ethanol,2,2-[(2-methylphenyl)imino]bis-
C11H17NO2 (195.12592220000002)
3-(2-methoxyphenoxy)-N-methylpropan-1-amine
C11H17NO2 (195.12592220000002)
4-Diethylamino-1,1,1-trifluorobut-3-en-2-one
C8H12F3NO (195.08709379999996)
1,2-Benzisoxazole-3-carboxylicacid, 4,5,6,7-tetrahydro-, ethyl ester
(S)-1-((3AR,4R,6AS)-5-BENZYL-2,2-DIMETHYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-C]PYRROL-4-YL)-ETHANE-1,2-DIOL
C11H17NO2 (195.12592220000002)
5-Pyrimidinecarboxylicacid,2-amino-4,6-dimethyl-,ethylester(9CI)
C9H13N3O2 (195.10077180000002)
1,1,1-trifluoro-4-isopropylaminopent-3-en-2-one
C8H12F3NO (195.08709379999996)
2-Amino-2-adamantanecarboxylic acid
C11H17NO2 (195.12592220000002)
ethyl (E)-2-cyano-3-ethyl-2-methyl-pent-3-enoate
C11H17NO2 (195.12592220000002)
1-(3,4-dimethoxyphenyl)propan-2-amine
C11H17NO2 (195.12592220000002)
(4-METHYL-PYRIDIN-2-YLOXY)-ACETIC ACID ETHYL ESTER
pargyline hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Buramate
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
2-Methyl-2-propanyl allyl(2-propyn-1-yl)carbamate
C11H17NO2 (195.12592220000002)
4-Amino-1-adamantanecarboxylic acid
C11H17NO2 (195.12592220000002)
1H-Pyrrolo[2,3-b]pyridin-3-amine, 5-ethoxy-4-fluoro-
(4-morpholinopyrimidin-2-yl)methanol
C9H13N3O2 (195.10077180000002)
[4-[2-(dimethylamino)ethoxy]phenyl]methanol
C11H17NO2 (195.12592220000002)
methyl 4-formyl-1,2,5-trimethylpyrrole-3-carboxylate
2-methoxy-N-(2-phenoxyethyl)ethanamine
C11H17NO2 (195.12592220000002)
Benzoic acid, 5-amino-2-methoxy-, ethyl ester (9CI)
(2-(tert-butoxy)pyridin-3-yl)boronic acid
C9H14BNO3 (195.10666840000002)
8-amino-8-tricyclo[5,2,1,0(2,6)]decanecarboxylic acid
C11H17NO2 (195.12592220000002)
Carbamic acid, 4-pyridazinyl-, 1,1-dimethylethyl ester (9CI)
C9H13N3O2 (195.10077180000002)
4-Isoxazoleboronic acid pinacol ester
C9H14BNO3 (195.10666840000002)
3,4-DIETHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER
C11H17NO2 (195.12592220000002)
Urea, N-(1,2-dihydro-2-oxo-3-pyridinyl)-N-propyl- (9CI)
C9H13N3O2 (195.10077180000002)
1-(3-Fluoro-2-pyridinyl)-4-methylpiperazine
C10H14FN3 (195.11716959999998)
Ethyl 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1-carboxylate
C9H13N3O2 (195.10077180000002)
cis-4-AMino-1-AdaMantane Carboxylic Acid
C11H17NO2 (195.12592220000002)
1-((2S)PYRROLIDIN-2-YL)-2-FLUORO-4-METHOXYBENZENE
C11H14FNO (195.10593659999998)
(R)-2-(5-fluoro-2-methoxyphenyl)pyrrolidine
C11H14FNO (195.10593659999998)
(S)-1-(6-Methoxy-pyriMidin-4-yl)-pyrrolidin-3-ol
C9H13N3O2 (195.10077180000002)
(R)-1-(6-Methoxy-pyriMidin-4-yl)-pyrrolidin-3-ol
C9H13N3O2 (195.10077180000002)
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-oxazole
C9H14BNO3 (195.10666840000002)
6-methyl-2-(propan-2-ylamino)pyrimidine-4-carboxylic acid
C9H13N3O2 (195.10077180000002)
(-)-(1S,4R)-N-FMOC-4-AMINOCYCLOPENT-2-ENECARBOXYLICACID
C11H17NO2 (195.12592220000002)
tert-butyl 3-ethynylpyrrolidine-1-carboxylate
C11H17NO2 (195.12592220000002)
tert-Butyl 2-amino-2-methylpropanoate hydrochloride
4-[1-Hydroxy-2-(isopropylamino)ethyl]phenol
C11H17NO2 (195.12592220000002)
methyl 4-acetyl-2,5-dimethyl-1h-pyrrole-3-carboxylate
6-methyl-2-(propylamino)pyrimidine-4-carboxylic acid
C9H13N3O2 (195.10077180000002)
propan-2-yl 3-(hydroxymethyl)pyridine-2-carboxylate
1H-Isoindole-1,3(2H)-dione,3a,4,7,7a-tetrahydro-2-(2-hydroxyethyl)-
(4-METHOXY-BENZYL)-(2-METHOXY-ETHYL)-AMINE
C11H17NO2 (195.12592220000002)
3-(2-Fluoro-phenoxymethyl)-pyrrolidine
C11H14FNO (195.10593659999998)
tert-Butyl 2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate
C11H17NO2 (195.12592220000002)
1H-Azepine, hexahydro-1-(trifluoroacetyl)- (9CI)
C8H12F3NO (195.08709379999996)
Ethyl dimethyl ammonio propane sulfonate
C7H17NO3S (195.09290919999998)
N-(3-Aminopropyl)-2-nitrobenzenamine
C9H13N3O2 (195.10077180000002)
2-Methyl-6-(2-phenylethenyl)pyridine
(E/Z)-SIB-1893 is a racemic compound of (E)-SIB-1893 and (Z)-SIB-1893 isomers. (E)-SIB-1893 is a selective non-competitive metabotropic glutamate subtype 5 receptor (mGluR5) antagonist[1].
2-Amino-4-hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine
2-(3,5-Dimethoxy-4-methylphenyl)ethanamine
C11H17NO2 (195.12592220000002)
N-(2-aminoethyl)ethane-1,2-diamine;2-(chloromethyl)oxirane
C7H18ClN3O (195.11383279999998)
Racemetirosine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
EU-0100093
N-acetyldopamine (NADA) is a catecholamine that is used by insects as sclerotizing precursors to harden their cuticle[1].
(2S)-2-ammonio-3-(4-hydroxy-3-methylphenyl)propanoate
5-Hydroxymethyl-1-neopentylpyrrole-2-carbaldehyde
C11H17NO2 (195.12592220000002)
Metyrosine
An L-tyrosine derivative that consists of L-tyrosine bearing an additional methyl substituent at position 2. An inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. C - Cardiovascular system > C02 - Antihypertensives > C02K - Other antihypertensives > C02KB - Tyrosine hydroxylase inhibitors C471 - Enzyme Inhibitor > C2155 - Tyrosine Hydroxylase Inhibitor D004791 - Enzyme Inhibitors
alpha-[3-(Nitrosoamino)propyl]-3-pyridinemethanol
C9H13N3O2 (195.10077180000002)
3-methyl-L-tyrosine zwitterion
An amino acid zwitterion resulting from a transfer of a proton from the carboxy to the amino group of 3-methyl-L-tyrosine; major species at pH 7.3.
SK&F 86466
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Phenol, 4-(2-aminopropoxy)-3,5-dimethyl-
C11H17NO2 (195.12592220000002)
[2-(2-aminopropoxy)-3-methylphenyl]methanol
C11H17NO2 (195.12592220000002)
N-acetyloctopamine
A member of the class of tyramines that is octopamine in which one of the amino hydrogens is replaced by an acetyl group. It is a metabolite of octopamine which is found in the brains of ants and fruit flies.
methyl 5-[(1r)-1-methoxyethyl]pyridine-3-carboxylate
1-[(1r,4r,6s)-4-hydroxy-9-azabicyclo[4.2.1]non-2-en-2-yl]propan-1-one
C11H17NO2 (195.12592220000002)
2-amino-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione
C11H17NO2 (195.12592220000002)
2-[(1r)-2,6,6-trimethyl-5-oxocyclohex-2-en-1-yl]ethanimidic acid
C11H17NO2 (195.12592220000002)
n-[2-hydroxy-5-(methoxymethyl)phenyl]ethanimidic acid
2-[(1s)-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]ethanimidic acid
C11H17NO2 (195.12592220000002)